SHALINI , Kumar et al. To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients with Type 2 Diabetes Mellitus. International Journal of Research in Pharmacy and Life Sciences, [S. l.], v. 12, n. 02, p. 31–37, 2024. DOI: 10.30904/j.ijrpls.2024.4722. Disponível em: https://pharmaresearchlibrary.org/journals/index.php/ijrpls/article/view/396. Acesso em: 18 apr. 2026.